An Assessment of the Health System Impacts of Direct-To-Consumer Advertising of Prescription Medicines. Vol. IV.

AuthorsMintzes, Kazanjian A, Bassett K, Lexchin J
SourcePills, Persuasion and Public Health Policies. Report of an Expert Survey on Direct-to-Consumer Advertising of Prescription Drugs in Canada, the United States and New Zealand. Vancouver (BC): Centre for Health Services and Policy Research; June 2001. (56 pages)
AbstractDirect-to-consumer prescription drug advertising (DTCA) is controversial, with many claims made about potential benefits and harm. This is a survey of pharmaceutical policy experts in sectors directly affected by DTCA in the two countries where DTCA is legal, the United States and New Zealand, as well as in Canada, which does not currently allow prescription drug advertising aimed at the public, but is strongly affected by US cross-border advertising. Canada is currently reviewing its legislation and considering introducing DTCA.
CodeHPRU 02:04D

a place of mind, The University of British Columbia

UBC Centre for Health Services and Policy Research
201 - 2206 East Mall, Vancouver BC, V6T 1Z3
Tel: 604.822.4969
Fax: 604.822.5690
E-mail: enquire@chspr.ubc.ca

Emergency Procedures | Accessibility | Contact UBC | © Copyright The University of British Columbia